As a result of our increased understanding of the pathogenesis of thyroid cancer, aberrant activation of MEK/ERK and/or phosphatidylinositol-3 kinase (PI3K)/AKT pathways are known to play fundamental roles in thyroid cancer progression [6, 7]. The gene discussed is MAP2K7; the disease is thyroid cancer.